niagenbioscience.com - Wutah dodolan YoY (TTM) NAGE

Chromadex Corp maintains high environmental sustainability through the implementation of ESG standards and plastic recycling. The revenue trend over four quarters year-over-year confirms this stability, with -1.90 serving as the base parameter value. Effective management is successfully commercializing anti-aging patents, while the absence of geopolitical risks and sanctions provides the company with a neutral backdrop for growth.
Chromadex Corp - rincian analitis lan metrik utama (NAGE)

The development of the R&D pipeline at Chromadex Corp (NAGE) in cellular metabolism and the launch of new biomedical ingredients translate directly into market share expansion. This trend is reflected in the rolling annual revenue growth over the last four quarters, which measures the pace of business scaling; the acceleration of this trend in the rolling four-quarter revenue growth rate minimizes the risk of a price drawdown.